Lily Tang

1.0k citations
44 papers · 788 indexed · h-index 17
Topics
Neuroscience and Neuropharmacology Research (11 papers)Receptor Mechanisms and Signaling (6 papers)Parkinson's Disease Mechanisms and Treatments (4 papers)

In The Last Decade

Lily Tang

43 papers receiving 715 citations

Peers

Lily Tang
Comparison fields: 5 of 125
  • Molecular Biology 213
  • Cellular and Molecular Neuroscience 191
  • Neurology 136
  • Physiology 101
  • Oncology 80
Replace K. Nandy with:
K. Nandy United States
Sheng Chen Canada
Giampiero Ferraguti Italy
N. Callaghan Ireland
Ru‐Jing Ren China
Marta Kowalska Poland
Dieter Platt Germany
Nieves González Spain
Evelyn Ferri Italy
Provvidenza Maria Abruzzo Italy
Lily Tang relative to K. Nandy United States K. Nandy's profile →
Citations per field
00.5×10×
K. Nandy · 1×
Citations per year

Countries citing papers authored by Lily Tang

Since Specialization
Citations

This map shows the geographic impact of Lily Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily Tang more than expected).

Fields of papers citing papers by Lily Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lily Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily Tang. The network helps show where Lily Tang may publish in the future.

Co-authorship network of co-authors of Lily Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Lily Tang. A scholar is included among the top collaborators of Lily Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lily Tang. Lily Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 10
3 7
4 1
5 18
6 61
7 10
8 38
9 28
10 1
11 8
12 9
13 13
14 4
15 20
16 28
17 36
18 79
19 22
20 21

About Lily Tang

Lily Tang is a scholar working on Aging, Cellular and Molecular Neuroscience and Neuropsychology and Physiological Psychology, having authored 44 papers that have together received 788 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). The work is most often cited by research in Aging (23 citations), Biological Psychiatry (27 citations) and Cellular and Molecular Neuroscience (191 citations). Lily Tang has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include George C. Cotzias, Samuel T. Miller, James Z. Ginos, Paul S. Papavasiliou, Eduardo Tolosa, Dale T. Umetsu, Suwat Benjaponpitak, Rosemarie H. DeKruyff, Lucille S. Hurley and Kathy Keller. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026